Pharmaceuticals
-
Australia reports on PrEP success
Rapid and high coverage roll-out of PrEP programme can have a dramatic impact on the spread of HIV, Australian researchers report today. Read more
-
Fasting as treatment for type 2 diabetes
A new series of case studies published today (10 October) highlight the potential effectiveness of therapeutic fasting to reverse insulin resistance in type 2 diabetes. Read more
-
No evidence statins work on non-cardiovascular conditions
There is not enough evidence to suggest statins, used to treat heart disease, could be beneficial for other conditions, according to a new analysis. Read more
-
Old’ antibiotic could treat melanoma
An old antibiotic could help to treat melanoma, British researchers have reported. Read more
-
Testosterone to aid diabetes?
Testosterone therapy may be able to improve diabetes symptoms and reverse its progress in some men, a European conference has heard. Read more
-
Antidepressant withdrawal underestimated
Millions of antidepressant users in the UK are potentially affected by withdrawal symptoms. Read more
-
New vaccine approach to tropical disease prevention
Clinical trials are about to start on a new generation of vaccines for tropical diseases caused by RNA viruses, British researchers have reported. Read more
-
Paracetamol use in infancy linked to asthma risk
Children who take paracetamol before the age of two years may face an increased risk of developing asthma by the age of 18, especially if they have specific variants in one particular gene, a European conference will hear today. Read more
-
Media blamed for diverting cash to ineffective drugs
A multi-million pound cancer drugs fund was over-hyped in the media, leading to NHS cash being diverted from effective care, experts say today. Read more
-
England split by pain divide
England suffers a clear North-South geographical split in rates of chronic pain, according to an analysis published today. Read more
